Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 4, 2001
Transforming growth factor-beta1 inhibits beta2-adrenoceptor gene transcription
J C Mak, J Rousell, E B Haddad, et al.
The Journal of Biological Chemistry
|
March 31, 1995
Transcriptional down-regulation of m2 muscarinic receptor gene expression in human embryonic lung (HEL 299) cells by protein kinase C
J Rousell, E B Haddad, J C Mak, et al.
Molecular Pharmacology
|
May 1, 1996
Transforming growth factor-beta 1 induces transcriptional down-regulation of m2 muscarinic receptor gene expression
E B Haddad, J Rousell, J C Mak, et al.
European Journal of Pharmacology
|
December 13, 1988
Muscarinic receptor subtypes mediating vasodilation in the pulmonary artery
D G McCormack, J C Mak, P Minette, et al.
Life Sciences
|
January 1, 1993
Visualization of muscarinic m4 mRNA and M4 receptor subtype in rabbit lung
J C Mak, E B Haddad, N J Buckley, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
September 1, 1989
Calcitonin gene-related peptide vasodilation of human pulmonary vessels
D G McCormack, J C Mak, M O Coupe, et al.
The Journal of Clinical Investigation
|
July 1, 1995
Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo
J C Mak, M Nishikawa, H Shirasaki, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
June 14, 2000
G(i)-dependent suppression of beta(1)-adrenoceptor effects in ventricular myocytes from NE-treated guinea pigs
H K Ranu, J C Mak, P J Barnes, et al.
American Journal of Respiratory Cell and Molecular Biology
|
January 1, 1994
Long-term exposure to norepinephrine results in down-regulation and reduced mRNA expression of pulmonary beta-adrenergic receptors in guinea pigs
M Nishikawa, J C Mak, H Shirasaki, et al.
Life Sciences
|
January 1, 1995
Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease
P J Barnes, M G Belvisi, J C Mak, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 4, 2001
Transforming growth factor-beta1 inhibits beta2-adrenoceptor gene transcription
J C Mak, J Rousell, E B Haddad, et al.
The Journal of Biological Chemistry
|
March 31, 1995
Transcriptional down-regulation of m2 muscarinic receptor gene expression in human embryonic lung (HEL 299) cells by protein kinase C
J Rousell, E B Haddad, J C Mak, et al.
Molecular Pharmacology
|
May 1, 1996
Transforming growth factor-beta 1 induces transcriptional down-regulation of m2 muscarinic receptor gene expression
E B Haddad, J Rousell, J C Mak, et al.
European Journal of Pharmacology
|
December 13, 1988
Muscarinic receptor subtypes mediating vasodilation in the pulmonary artery
D G McCormack, J C Mak, P Minette, et al.
Life Sciences
|
January 1, 1993
Visualization of muscarinic m4 mRNA and M4 receptor subtype in rabbit lung
J C Mak, E B Haddad, N J Buckley, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
September 1, 1989
Calcitonin gene-related peptide vasodilation of human pulmonary vessels
D G McCormack, J C Mak, M O Coupe, et al.
The Journal of Clinical Investigation
|
July 1, 1995
Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo
J C Mak, M Nishikawa, H Shirasaki, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
June 14, 2000
G(i)-dependent suppression of beta(1)-adrenoceptor effects in ventricular myocytes from NE-treated guinea pigs
H K Ranu, J C Mak, P J Barnes, et al.
American Journal of Respiratory Cell and Molecular Biology
|
January 1, 1994
Long-term exposure to norepinephrine results in down-regulation and reduced mRNA expression of pulmonary beta-adrenergic receptors in guinea pigs
M Nishikawa, J C Mak, H Shirasaki, et al.
Life Sciences
|
January 1, 1995
Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease
P J Barnes, M G Belvisi, J C Mak, et al.
Page
of 7